Arthur F. Ryan - 03 Jan 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Issuer symbol
REGN
Transactions as of
03 Jan 2022
Net transactions value
-$62,495
Form type
4
Filing time
05 Jan 2022, 15:22:19 UTC
Previous filing
02 Dec 2021
Next filing
02 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $622 -1 -0% $621.98 22,490 03 Jan 2022 Direct F1
transaction REGN Common Stock Sale $4,980 -8 -0.04% $622.52 22,482 03 Jan 2022 Direct F1, F2
transaction REGN Common Stock Sale $11,849 -19 -0.08% $623.62 22,463 03 Jan 2022 Direct F1, F3
transaction REGN Common Stock Sale $8,740 -14 -0.06% $624.30 22,449 03 Jan 2022 Direct F1, F4
transaction REGN Common Stock Sale $28,150 -45 -0.2% $625.56 22,404 03 Jan 2022 Direct F1, F5
transaction REGN Common Stock Sale $3,132 -5 -0.02% $626.48 22,399 03 Jan 2022 Direct F1, F6
transaction REGN Common Stock Sale $3,763 -6 -0.03% $627.22 22,393 03 Jan 2022 Direct F1, F7
transaction REGN Common Stock Sale $1,258 -2 -0.01% $628.87 22,391 03 Jan 2022 Direct F1, F8
transaction REGN Common Stock Award $0 +191 +0.85% $0.000000 22,582 03 Jan 2022 Direct F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +2,707 $0.000000 2,707 03 Jan 2022 Common Stock 2,707 $625.60 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 8 shares of Company stock on January 3, 2022 at prices ranging from $622.32 to $622.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price.
F3 Represents volume-weighted average price of sales of 19 shares of Company stock on January 3, 2022 at prices ranging from $623.41 to $623.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price.
F4 Represents volume-weighted average price of sales of 14 shares of Company stock on January 3, 2022 at prices ranging from $624.04 to $624.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price.
F5 Represents volume-weighted average price of sales of 45 shares of Company stock on January 3, 2022 at prices ranging from $625.00 to $625.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price.
F6 Represents volume-weighted average price of sales of 5 shares of Company stock on January 3, 2022 at prices ranging from $626.29 to $626.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price.
F7 Represents volume-weighted average price of sales of 6 shares of Company stock on January 3, 2022 at prices ranging from $627.00 to $627.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price.
F8 Represents volume-weighted average price of sales of 2 shares of Company stock on January 3, 2022 at prices ranging from $628.76 to $628.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2022 at each separate price.
F9 Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.
F10 On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.